About CSI
The Chinese Society for Immunology (CSI), a voluntary, academic, nonprofit and non-governmental organization, a family of over 10,000 members, is registered and established in accordance with the laws of China. CSI has grown out of the Chinese Committee for Immunology, founded in 1984, and joined the International Union of Immunological Societies (IUIS) as a member society in the same year. In 1988 CSI got its license and was affiliated with the China Association for Science and Technology (CAST). In 1992, CSI became a founder member of the Federation of Immunological Societies of Asia-Oceania (FIMSA) and started to play an active role in the regional academic organization. Since 2016, the FIMSA office has been sharing with CSI office in Beijing, which is led by FIMSA Secretary General.
Read More
Journal
Cellular & Molecular Immunology is a monthly journal from the Chinese Society for Immunology and the University of Science and Technology of China. Covering both basic immunology research and clinical applications, CMI provides the latest information and advancements in our understanding of the immunological response of the host, both in vitro and in vivo.
News
-

Empowering Primary Care Doctors: CSI Brings Advanced Immunology to Rural Grassroots Healthcare
Global advancements in immunology have transformed modern healthcare, and major teaching hospitals in China's metropolis centers now operate at the cutting edge of this discipline. However, as a developing country, a significant disparity remains at the rural grassroots level. While immunological disorders affect rural populations just as frequently, many primary care physicians lack formal training and up-to-date knowledge in basic immunology. Bridging this knowledge gap through specialized education for primary care doctors is vital for improving early detection, standardized treatment, and overall healthcare equity in underserved communities.07
2026 -

Summer School 2026 of CSI
The 13th CSI Summer School, hosted by the Chinese Society for Immunology (CSI) and co-organized by Ningxia Medical University and the Ningxia Society for Immunology, was held from July 10 to 19, 2026, in Yinchuan, Ningxia Hui Autonomous Region. Over 90 doctoral students from universities and research institutes across China participated in the 10-day intensive program.31
2026 -

Summary of the 19th National Congress of Cancer Biotherapy & National Congress of Cancer Cell Therapy and Immunotherapy
The 19th National Congress of Cancer Biotherapy & National Congress of Cancer Cell Therapy and Immunotherapy was grandly held in Wuhan, Hubei Province, from May 22 to 24, 2026. Hosted by the Chinese Society for Immunology (CSI), the congress attracted 500 registered delegates and received 207 abstract submissions, showcasing the immense vitality and academic cohesion of China's cancer biotherapy field.03
2026 -

Report on the AAI-CSI Joint Symposium at the 2026 American Association of Immunologists Annual Meeting
The Annual Meeting of the American Association of Immunologists (AAI 2026) was convened in Boston from April 15 to 19, 2026. Attended by approximately 3,000 delegates, the congress presented a comprehensive scientific program encompassing fundamental immunology, clinical translational medicine, neuroimmunology, artificial intelligence in immunology, and emerging immunotherapeutic technologies.06
2026
Links






















